Matt Schumann
VP of Finance
Professional Overview
Matt Schumann is a seasoned finance executive with over 12 years of experience in the life sciences and healthcare industries. As the Vice President of Finance at Aerami Therapeutics, he is responsible for leading the company's financial operations, strategic planning, and driving business performance.
Experience Summary
Current Role
As the VP of Finance at Aerami Therapeutics, Matt oversees all aspects of the company's financial management, including budgeting, forecasting, reporting, and compliance. He works closely with the executive team to develop and implement financial strategies that support Aerami's growth and operational objectives. Under his leadership, the finance department has improved financial reporting processes, enhanced cash flow management, and implemented robust internal controls to ensure the company's financial stability and integrity.
Career Progression
Prior to his current role, Matt served as the VP, Corporate Controller at Aerami Therapeutics, where he spearheaded the integration of financial systems and processes following the company's acquisition. Before that, he held the position of Director of Finance & Accounting at Clarus Therapeutics, where he was instrumental in streamlining the company's financial operations and implementing data-driven decision-making processes. Matt's earlier experience includes roles as Chief Financial Officer at McCaulley Dowell LLP and Director of Finance at SMS Assist, L.L.C., where he demonstrated his expertise in financial planning, analysis, and strategic leadership.
Academic Background
Matt holds a Bachelor of Science in Accounting from the University of Illinois at Urbana-Champaign. He is a Certified Public Accountant (CPA) and has completed additional executive education programs in corporate finance and strategic management.
Areas of Expertise
- Financial management and reporting
- Budgeting and forecasting
- Financial planning and analysis
- Mergers and acquisitions
- Internal controls and compliance
- Strategic decision-making
- Cross-functional collaboration
Professional Impact
During his tenure at Aerami Therapeutics, Matt has played a pivotal role in the company's financial transformation. He spearheaded the implementation of a new enterprise resource planning (ERP) system, which has improved data accuracy, streamlined financial processes, and enhanced the company's ability to make data-driven decisions. Additionally, Matt's strategic guidance has been instrumental in securing $50 million in funding to support Aerami's clinical development pipeline and expand its commercial footprint.
Conclusion
With his extensive experience in the life sciences industry and demonstrated track record of financial leadership, Matt Schumann is poised to continue driving Aerami Therapeutics' financial success and supporting the company's growth and innovation efforts.
